TVTX

Travere Therapeutics, Inc. (TVTX) Scenario Analysis Analysis (2026)

Invetso Score: 5/10 — Balanced · Last Updated: 2026-08-01

Overall Score

Base Case

TVTX remains a high-burn, pre-profitability profile with negative TTM margins and a very high EV/Sales multiple, so the base case still assumes execution risk remains elevated.

Liquidity is adequate in the near term with a current ratio above 4.0 and cash per share of 5.23, but leverage remains heavy with debt-to-equity at 25.16x and interest coverage still negative.

Bull Case

A bull scenario still depends on meaningful operating leverage from the company’s very high gross margin profile (94.4%) translating into sustained margin expansion.

If revenue growth accelerates and cash burn narrows, the current balance-sheet liquidity could support a rerating from today’s elevated valuation base.

Bear Case

The bear case remains centered on persistent losses, weak returns on capital, and a negative interest coverage ratio, which could pressure the equity if execution slips.

With EV/FCF still extremely elevated and profitability still negative, any slowdown in growth or funding pressure would likely compress the multiple further.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Travere Therapeutics, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →